MedTrace Logo

Changes in Biomarkers Associated With Use of Electronic Cigarettes

NCT03084315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 234

Last updated 2021-08-26

Study results available
· View outcomes & findings →

Summary

The objective of this clinical trial was to compare the effects of e-cigarettes with and without nicotine on patterns of combustible cigarette use and biomarkers of exposure to tobacco toxicants among African American smokers.

Conditions

  • Biomarkers

Interventions

DEVICE

E-Cig Zero Nicotine

E-Cig Zero Nicotine

DEVICE

E-Cig 24mg Nicotine

E-Cig 24mg Nicotine

Sponsors & Collaborators

Principal Investigators

  • Anne Joseph, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-15
Primary Completion
2019-03-08
Completion
2019-03-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03084315 on ClinicalTrials.gov